This course is co-organised by ERS and the ESTS

Potentially operable lung cancer

Organisers : Gilbert Massard and Bogdan Grigoriu

This course, co-organised by ERS and the European Society of Thoracic Surgeons (ESTS) provides an update on the screening, management and treatment options for patients with potentially operable lung cancer. The course format alternates between state-of-the-art lectures, case-based teaching and interactive multidisciplinary workshops.

An application for CME accreditation will made to the European Accreditation Council for Continuing Medical Education (EACCME). The number of credits granted corresponds to attendance during the onsite course. Please note that you need to sign the register of attendance each day to ensure that you receive the CME credits.

Target audience

The course fits well into the continuing professional development of thoracic surgeons, pulmonary physicians, radiation oncologists and medical oncologists. It may also appeal to trainee specialists in these four fields.


  • Screening
  • Classification of lung cancer
  • New diagnostic tools
  • Early-stage lung cancer
  • Alternative treatments
  • Surgery for early-stage small cell lung cancer
  • Perioperative treatments
  • Surgery for advanced disease
  • Complex situations
  • Innovative treatments
  • Patient safety and quality of life
Practical Information
€ 600 Early Career
ERS Members
€ 700 ERS/ESTS members € 800 Non-ERS Members € 1200 Industry
(ERS Members & non-Members)

The Member fee is applicable to active ERS and ESTS members at the time of registration. The fee includes two nights’ accommodation.

Register before the early-bird deadline on 25 January, 2019 to benefit from a €50 discount on registration fees.

Cancellation policy

Travel Info

Registering for someone else ? Contact Sandy Borlat


There are no bursaries available for this course.